Travere Therapeutics TVTX

$ 51.99 1.46%

Quarterly report 2026-Q3
added 11-02-2026

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	89.2 M
Market Cap^[1]	$ 4.64 B
EBITDA (LTM)	$ -82.4 M
P/E (LTM)	-29.789157
P/S (LTM)	6.77617
EPS (LTM)	-1.66

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.